A sequel for beginners, part 2: ligand-based drug design — the basics

webinar

Tue, 18 Feb 2014, 17:00 CET (Berlin)

A sequel for beginners, part 2: ligand-based drug design — the basics

“But we don’t have a protein structure!&quot – it’s a common complaint in drug hunting. In fact, you don’t have your back to the wall if you need to spot active compounds in this situation! In this BioSolveIT webinar, you will learn the background to basic techniques such as ligand superposition. By the end of the hour, you will have learned how the impossible becomes possible, intelligently mining for interesting and synthetically feasible leads from gigantically large spaces of potential compounds in just a few minutes.

Current news

VAST Just Got Bigger — The September 2026 Update
September 17, 2026 09:00 CEST
More compounds. More chemistry. More opportunities to discover your next active. This August, explore Enamine’s largest compound catalog with infiniSee xREAL as BioSolveIT’s Tool of the Month. XtalPi has expanded its VAST Chemical Space, giving you access to almost six billion virtual product molecules built from over 25,000 carefully selected...
Read on
category
Events
Boston Event: Expanding Molecular Diversity with CORE
September 15, 2026 17:27 CEST
Chemical Space Exploration Meets AI in Boston BioSolveIT and Onepot.AI invite you to an evening of science, drinks, and conversation at D16, the speakeasy beneath Dillon’s in Boston. Join us on September 30, 2026, for two very concise presentations exploring how ultra-large Chemical Spaces and artificial intelligence can open new...
Read on
category
Events
Beyond the Flatland: sp³-Rich Fragments Unlock Novel Kinase Chemotypes: Free Webinar!
September 15, 2026 10:40 CEST
Kinases are among the most intensively pursued target families in drug discovery, yet the chemical matter screened against them remains surprisingly narrow. Conventional kinase-focused libraries are dominated by flat, heteroaromatic compounds, while saturated, three-dimensional molecules stay largely underexplored. That narrow structural diversity makes it harder to find genuinely novel chemotypes,...
Read on